Insulin resistance doesn’t show up on a standard blood sugar test until it has progressed significantly. Most people with insulin resistance have normal glucose levels for years because their pancreas compensates by pumping out extra insulin. Diagnosing it requires looking beyond glucose, using a combination of blood tests, physical signs, and metabolic markers that reveal the problem earlier.
Why Standard Blood Sugar Tests Miss It
A routine fasting glucose test measures how much sugar is in your blood after an overnight fast. But it tells you nothing about how hard your body is working to keep that number normal. Someone with insulin resistance may have a perfectly normal fasting glucose of 90 mg/dL while their pancreas is producing three or four times the normal amount of insulin to achieve that result. By the time fasting glucose creeps above 100 mg/dL (the threshold for prediabetes), insulin resistance has typically been present for years.
This is why catching insulin resistance early means measuring insulin itself, not just glucose.
Fasting Insulin: The Most Accessible Test
A fasting insulin test is a simple blood draw after 8 to 12 hours without food. Most labs flag results as “normal” if they fall below 25 μIU/mL, but that upper limit is misleadingly generous. Research on metabolic health consistently shows that people with fasting insulin below 5 μIU/mL have significantly better insulin sensitivity and lower rates of metabolic syndrome and diabetes.
The gap between 5 and 25 is where things get interesting. For every 1 μIU/mL increase above 5, the risk of developing type 2 diabetes rises by roughly 5 to 7 percent, even though those levels are technically “normal” by lab standards. People with levels above 15 μIU/mL face about 1.5 times the risk of heart failure compared to those below 5. So a fasting insulin of 18 might not get flagged on your lab report, but it’s a meaningful signal that your body is already working harder than it should to manage blood sugar.
You can request a fasting insulin test from most primary care doctors, though it isn’t part of standard annual bloodwork. You may need to ask for it specifically.
HOMA-IR: Combining Insulin and Glucose
HOMA-IR is a calculation that uses both your fasting insulin and fasting glucose to estimate insulin resistance with a single score. The formula multiplies fasting insulin (in μIU/mL) by fasting glucose (in mg/dL), then divides by 405. Your doctor can calculate it from the same blood draw used for fasting glucose and fasting insulin.
A HOMA-IR score of 1.0 is considered ideal. Scores below 2.0 generally indicate normal insulin sensitivity. The most widely used cutoff for insulin resistance is 2.5 or above, though the European Group for the Study of Insulin Resistance uses a threshold of 2.0. For women with polycystic ovary syndrome (PCOS), research suggests a cutoff as low as 2.1 is appropriate for identifying insulin resistance.
HOMA-IR is practical because it requires only a single fasting blood sample, costs very little, and gives a more complete picture than either glucose or insulin alone. It’s the most commonly used tool in clinical research on insulin resistance and increasingly available in regular medical practice.
The Triglyceride-to-HDL Ratio
If you already have a standard lipid panel from recent bloodwork, you can calculate a useful proxy for insulin resistance without any additional testing. Divide your triglycerides by your HDL cholesterol. Both numbers appear on a basic cholesterol panel.
For White European men, a triglyceride-to-HDL ratio above 3.8 (using mg/dL units) signals likely insulin resistance. For White European women, the cutoff is lower at 2.0. South Asian men and women have different optimal cutoffs of 2.8 and 2.5 respectively. If your ratio exceeds these thresholds, it’s worth pursuing further testing with fasting insulin or HOMA-IR.
This ratio works because insulin resistance directly affects how your liver processes fats. When cells respond poorly to insulin, the liver produces more triglycerides and HDL levels tend to drop. The combination creates a recognizable pattern that tracks closely with results from more sophisticated testing.
Metabolic Syndrome Criteria
Metabolic syndrome is a cluster of conditions that often travel together, and insulin resistance is the common thread linking them. You meet the diagnosis if you have abnormalities in any three of these five measures:
- Waist circumference: 40 inches or more in men, 35 inches or more in women (lower cutoffs for Asian Americans: 35 inches for men, 31 inches for women)
- Triglycerides: 150 mg/dL or higher
- HDL cholesterol: below 40 mg/dL in men, below 50 mg/dL in women
- Blood pressure: 130/85 mmHg or higher
- Fasting glucose: 100 mg/dL or higher
Meeting three of these five criteria doesn’t just indicate metabolic syndrome. It strongly suggests underlying insulin resistance is driving the pattern. If you meet these thresholds, confirming with a fasting insulin level or HOMA-IR score adds clarity about how advanced the resistance is.
Physical Signs You Can Spot Yourself
Insulin resistance sometimes leaves visible clues on the body before blood tests become abnormal. The most distinctive is acanthosis nigricans: patches of dark, velvety skin that appear in body folds, most commonly the neck, armpits, and groin. These patches range from light brown to black and can feel thicker than surrounding skin. Small skin tags often accompany them. The darkening happens because high insulin levels stimulate skin cell growth in these areas.
Acanthosis nigricans is strongly associated with elevated insulin, and its presence in someone who is overweight or has a family history of diabetes is a reliable physical indicator of insulin resistance. If the underlying insulin levels improve through weight loss and dietary changes, the dark patches often fade.
Carrying excess weight around the midsection (an “apple” body shape rather than “pear”) is another visible pattern associated with insulin resistance, which is why waist circumference is one of the metabolic syndrome criteria.
The Gold Standard Test
The most precise measurement of insulin resistance is a procedure called the hyperinsulinemic-euglycemic clamp, developed in 1979. During this test, a clinician infuses insulin at a fixed rate while simultaneously adjusting a glucose drip to keep blood sugar at a constant, normal level. The amount of glucose needed to maintain stable blood sugar reveals exactly how sensitive your tissues are to insulin. If your cells respond well, more glucose has to be infused to prevent blood sugar from dropping. If your cells are resistant, very little glucose is needed because the insulin isn’t doing much.
This test takes about two hours and requires continuous monitoring. It is considered the gold standard in research but is almost never used in routine clinical care because of its complexity and cost. For most people, a combination of fasting insulin, HOMA-IR, and lipid ratios provides enough diagnostic information to guide decisions.
Putting the Results Together
No single number definitively diagnoses insulin resistance in isolation. The condition exists on a spectrum, and the most reliable picture comes from combining multiple markers. A fasting insulin above 10 μIU/mL, a HOMA-IR above 2.0, a triglyceride-to-HDL ratio above the ethnicity-specific threshold, and any visible signs like darkened skin folds collectively paint a much clearer picture than any one test alone.
If you suspect insulin resistance, the most practical first step is asking for a fasting insulin level alongside your next fasting glucose test. These two numbers give you a HOMA-IR score and, combined with a lipid panel you may already have on file, provide a solid foundation for understanding where you stand.